BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38610096)

  • 1. Construct validity, reliability, and threshold value for treatment goals of the Thai version of the 12-item Psoriatic Arthritis Impact of Disease Questionnaire for patients with psoriatic arthritis.
    Chiowchanwisawakit P; Orawongpaisarn A; Katchamart W
    Int J Rheum Dis; 2024 Apr; 27(4):e15139. PubMed ID: 38610096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 12-item Psoriatic Arthritis Impact of Disease Questionnaire: Construct Validity, Reliability, and Interpretability in a Clinical Setting.
    Di Carlo M; Becciolini A; Lato V; Crotti C; Favalli EG; Salaffi F
    J Rheumatol; 2017 Mar; 44(3):279-285. PubMed ID: 27909086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation and clinical interpretability of PsAID - psoriatic arthritis impact of disease.
    da Cruz Ribeiro E Souza E; da Silva Carneiro SC; Yazbek MA; de Cássia Menin R; Campanholo CB; Carneiro JN; da Silva CHM; Ranza R
    Adv Rheumatol; 2020 Sep; 60(1):49. PubMed ID: 32962756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritis.
    Gossec L; Orbai AM; Coates LC; Gladman DD; Ogdie A; Pelligra CG; Ciaravino V; Ink B; Taieb V; Lambert J; de Wit M
    RMD Open; 2024 Jan; 10(1):. PubMed ID: 38296802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Psoriatic Arthritis Impact of Disease (PsAID) Questionnaire and its potential as a single-item outcome measure in clinical practice.
    Holland R; Tillett W; Korendowych E; Cavill C; Waldron N; Brooke M; McHugh NJ
    Ann Rheum Dis; 2018 Mar; 77(3):343-347. PubMed ID: 29146740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the patient-perceived impact of psoriatic arthritis a global concept? An international study in 13 Arab countries (TACTIC study).
    Ziadé N; Abbas N; Hmamouchi I; El Kibbi L; Maroof A; Elzorkany B; Abdulateef N; Adnan A; Ihsan Awadh N; Gorial FI; Alchama N; Haouichat C; Alnaimat F; Hannawi S; Atawnah S; Halabi H; Al Mashaleh M; Aljazwi L; Abogamal A; Ayoub L; Bouajina E; Bahiri R; Saad S; Sabkar M; Aouad K; Gossec L
    Rheumatol Int; 2024 May; 44(5):885-899. PubMed ID: 38498150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease activity and functional status associated with health-related quality of life and patient-acceptable symptom state in patients with psoriatic arthritis in Thailand: A cross-sectional study.
    Chiowchanwisawakit P; Srinonprasert V; Thaweeratthakul P; Katchamart W
    Int J Rheum Dis; 2019 Apr; 22(4):700-707. PubMed ID: 30666824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel role for the psoriatic arthritis impact of disease (PsAID) questionnaire.
    Johnson K; Ye JY; Chandran V; Gladman DD
    Semin Arthritis Rheum; 2019 Oct; 49(2):241-245. PubMed ID: 31101369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriatic arthritis impact of disease questionnaire: validity, reliability and its clinical potential.
    Güler T; Bora Karslı P; Ataman Ş; Bodur H
    Rheumatol Int; 2020 Jun; 40(6):959-967. PubMed ID: 32270296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative.
    Gossec L; de Wit M; Kiltz U; Braun J; Kalyoncu U; Scrivo R; Maccarone M; Carton L; Otsa K; Sooäär I; Heiberg T; Bertheussen H; Cañete JD; Sánchez Lombarte A; Balanescu A; Dinte A; de Vlam K; Smolen JS; Stamm T; Niedermayer D; Békés G; Veale D; Helliwell P; Parkinson A; Luger T; Kvien TK;
    Ann Rheum Dis; 2014 Jun; 73(6):1012-9. PubMed ID: 24790067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Psoriatic Arthritis Impact of Disease 12-item questionnaire: equivalence, reliability, validity, and feasibility of the touch-screen administration versus the paper-and-pencil version.
    Salaffi F; Di Carlo M; Carotti M; Farah S; Gutierrez M
    Ther Clin Risk Manag; 2016; 12():631-42. PubMed ID: 27143906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Thai version of the Health Assessment Questionnaire for patients with psoriatic arthritis.
    Katchamart W; Benjamanukul S; Chiowchanwesawakit P
    Int J Rheum Dis; 2014 Feb; 17(2):181-5. PubMed ID: 24618364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease features associated with a low disease impact in patients with psoriatic arthritis: results of a cross-sectional multicenter study.
    Queiro R; Cañete JD; Montoro M; Gómez S; Cábez A;
    Arthritis Res Ther; 2020 Apr; 22(1):82. PubMed ID: 32295620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: association with disease activity and quality of life indices.
    Lubrano E; Scriffignano S; Azuaga AB; Ramirez J; Cañete JD; Perrotta FM
    RMD Open; 2020 Mar; 6(1):. PubMed ID: 32179713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the Patient-Reported Physical Function Outcome Measures in a Real-Life International Cohort of Patients With Psoriatic Arthritis.
    Leung YY; Orbai AM; de Wit M; Balanescu A; Dernis E; Soubrier M; Eder L; Smolen JS; Coates LC; Gossec L;
    Arthritis Care Res (Hoboken); 2021 Apr; 73(4):593-602. PubMed ID: 31961492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease Activity in Psoriatic Arthritis Index and Psoriatic Arthritis Impact of Disease Questionnaire: correlation and sensitivity to change in a real clinical setting.
    Pardo E; Charca L; Alonso S; Alperi M; Arboleya L; Queiro R
    Clin Exp Rheumatol; 2020; 38(5):973-977. PubMed ID: 31969229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring Outcomes in Psoriatic Arthritis: Comparing Routine Assessment of Patient Index Data and Psoriatic Arthritis Impact of Disease.
    Walsh JA; Wan MT; Willinger C; Husni ME; Scher JU; Reddy SM; Ogdie A
    J Rheumatol; 2020 Oct; 47(10):1496-1505. PubMed ID: 31575704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal disease activity and impact of disease in psoriatic arthritis: a Spanish cross-sectional multicenter study.
    Queiro R; Cañete JD; Montilla C; Abad M; Montoro M; Gómez S; Cábez A;
    Arthritis Res Ther; 2017 Mar; 19(1):72. PubMed ID: 28356155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construct validity of the ASAS health index in psoriatic arthritis: a cross-sectional analysis.
    Morante I; Aurrecoechea E; Villa I; Santos M; Riancho L; Queiro R
    Rheumatology (Oxford); 2021 Mar; 60(3):1465-1473. PubMed ID: 33011808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How do patient reported outcome measures affect treatment intensification and patient satisfaction in the management of psoriatic arthritis? A cross sectional study of 503 patients.
    Coyle C; Watson L; Whately-Smith C; Brooke M; Kiltz U; Lubrano E; Queiro R; Trigos D; Brandt-Juergens J; Choy E; D'Angelo S; Delle Sedie A; Dernis E; Wirth T; Guis S; Helliwell P; Ho P; Hueber A; Joven B; Koehm M; Morales CM; Packham J; Pinto Tasende JA; Garcia FJR; Ruyssen-Witrand A; Scrivo R; Twigg S; Welcker M; Soubrier M; Gossec L; Coates LC
    Rheumatology (Oxford); 2024 Jan; ():. PubMed ID: 38191998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.